Life Scientists, All Other
AI 替代率
60%这个岗位当前已结合 5 条时间线资讯和岗位画像推理来给出替代率。
人工智能模型在生命科学领域日益具备高级科学推理、假设生成和实验设计能力，通过专业平台和自动化数据分析，显著加速药物发现、基因组学和细胞研究。这使得工作流程转向模型驱动的研发，增强或取代了生命科学家许多传统研究任务。
替代率趋势
按周期刷新快照聚合- 2026-04-2065%
为什么是这个等级
结构底座OpenAI's GPT-Rosalind is a frontier reasoning model specifically designed to accelerate drug discovery, genomics analysis, protein reasoning, and overall scientific research workflows by synthesizing evidence, generating biological hypotheses, and planning experiments, directly impacting core scientific tasks traditionally performed by life scientists.
AI virtual cell platforms like Baiyao Technology's enable life scientists to simulate cell behavior and predict changes through large-scale virtual experiments. This shifts drug development from traditional 'experiment-driven' to 'model-driven' R&D, significantly augmenting and potentially replacing aspects of physical lab experimentation.
AI-native health hardware companies are developing miniature, high-precision automated biochemical analyzers for continuous, multi-modal biological data collection from various bodily fluids. This data, analyzed by AI Agents, supports proactive, personalized health management and streamlines the initial stages of data acquisition and interpretation for research.
Quantum computing is seeing accelerated development and commercial orders, with key applications emerging in drug screening, new materials, catalyst research, and biological medicine. These advanced computational tools offer the potential for further automation and augmentation of complex simulations and analyses crucial for life scientists.
时间线
按时间倒序展示相关资讯与案例文章详细介绍了量子计算产业的加速发展，这得益于逻辑量子比特和纠错技术的突破，带来了融资增加、IPO以及早期商业订单。关键应用正在金融、安防、药物筛选、新材料和催化剂研发等领域涌现，部分公司已在风险评估和生物医药等领域获得合作，预示着量子计算正从纯粹的实验用途转向实际的产业应用。
打开原文AI虚拟细胞（AIVC）平台公司百曜科技完成新一轮融资，将用于迭代AI虚拟细胞算法模型、建设数据收集平台及加速产业化落地。该技术将AI建模层级从“分子”提升至“细胞”，使生命科学家能够在数字环境中进行大规模虚拟实验，将研发流程从“实验驱动”转变为“模型驱动”，有望显著降低研发成本、缩短开发周期，并提升药物研发的整体成功率，从而深刻影响生命科学领域的工作方式。
打开原文AI原生健康硬件公司「杉木SHANMU」完成近亿元A轮融资。该公司开发微型高精度全自动生化分析仪，可嵌入马桶等日常用品中，持续无感地获取尿液、唾液、汗液中的分子、细胞、蛋白等生物指标。通过构建“个人健康计算”的生命操作系统，AI Agent与真人医生团队将基于连续多模态生物数据，实现预测式、个性化健康干预，彻底重构传统健康监测和管理的工作流程。
打开原文OpenAI introduced GPT-Rosalind, a specialized AI model and an accompanying Codex plugin for life sciences research. This tool is designed to accelerate biological and chemical discovery by synthesizing evidence, generating hypotheses, and planning experiments, streamlining traditionally fragmented workflows for scientists in areas like genomics and protein engineering.
打开原文OpenAI launched GPT-Rosalind, a new frontier reasoning model aimed at accelerating drug discovery, genomics analysis, protein reasoning, and overall scientific research workflows for life scientists.
打开原文